{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:05:17Z","timestamp":1768359917981,"version":"3.49.0"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.critrevonc.2025.105055","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:14:43Z","timestamp":1764202483000},"page":"105055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparison of the therapeutic potential of exosomes derived from different cells for the treatment of prostate cancer"],"prefix":"10.1016","volume":"217","author":[{"given":"Farhood Khaleghi","family":"Mehr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikoo","family":"Emtiazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Zolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasaman","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.critrevonc.2025.105055_bib1","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102196","article-title":"Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: a systematic review","volume":"51","author":"L\u00f3pez-Hern\u00e1ndez","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib4","first-page":"4","article-title":"The silent burden of de novo metastatic prostate cancer in the Middle East: a call for region-specific screening guidelines","volume":"6","author":"Abbas","year":"2025","journal-title":"Soci. \u00e9t\u00e9 Int. D. \u2019Urol. J."},{"key":"10.1016\/j.critrevonc.2025.105055_bib5","doi-asserted-by":"crossref","DOI":"10.14740\/wjon2519","article-title":"Time to treatment initiation of lung, breast, colorectal, and prostate cancers and contributing factors from 2015 to 2020 utilizing surveillance, epidemiology, and end results program database","author":"Di Vanna","year":"2025","journal-title":"World J. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11255-024-04266-4","article-title":"Effect of GLP-1 receptor agonists on prostate cancer risk reduction: a systematic review and meta-analysis","volume":"57","author":"Sharma","year":"2025","journal-title":"Int. Urol. Nephrol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.105055_bib7","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.105055_bib8","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib9","first-page":"1","article-title":"The association between statin use, genetic variation, and prostate cancer risk","author":"Amiri","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.critrevonc.2025.105055_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2018.00745","article-title":"Potential applications of nanotechnology in urological cancer","volume":"9","author":"He","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1186\/s12885-025-14505-1","article-title":"The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer","volume":"25","author":"Ahamed","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.105055_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/17562872221103988","article-title":"Biomarkers for prostate cancer detection and risk stratification","volume":"14","author":"Farha","year":"2022","journal-title":"Ther. Adv. Urol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3122\/jabfm.2024.240228R1","article-title":"Barriers and facilitators of shared decision making in prostate cancer treatment among african american men","volume":"38","author":"Anderson","year":"2025","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.critrevonc.2025.105055_bib14","article-title":"The contemporary management of prostate cancer","author":"Chakrabarti","year":"2025","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41419-022-05084-1","article-title":"Second generation androgen receptor antagonists and challenges in prostate cancer treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2025.105055_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2025.06.008","article-title":"Evaluating treatment efficacy in metastatic hormone-sensitive prostate cancer patients with visceral disease: a systematic review and network meta-analysis","author":"Flauto","year":"2025","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","article-title":"Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer","volume":"21","author":"Han","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2013.04.010","article-title":"Diverse mechanisms of somatic structural variations in human cancer genomes","volume":"153","author":"Yang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.105055_bib19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/IJN.S301552","article-title":"Dual-functional PLGA nanoparticles co-loaded with indocyanine green and resiquimod for prostate cancer treatment","author":"Lin","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2025.105055_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3389\/fphys.2019.01569","article-title":"A role for exosomes in craniofacial tissue engineering and regeneration","volume":"10","author":"Cooper","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2020.01.002","article-title":"Poor clinical outcomes of intratumoral dendritic cell\u2013specific intercellular adhesion molecule 3\u2013grabbing non-integrin\u2013positive macrophages associated with immune evasion in gastric cancer","volume":"128","author":"Liu","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/cancers17071064","article-title":"Immunotherapy in prostate cancer: from a \u201cCold\u201d tumor to a \u201cHot\u201d prospect","volume":"17","author":"Kwon","year":"2025","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.trecan.2020.02.013","article-title":"Immune cell-derived exosomes in the cancer-immunity cycle","volume":"6","author":"Yan","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.critrevonc.2025.105055_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cca.2019.10.022","article-title":"Exosomes: current use and future applications","volume":"500","author":"Chung","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1872-2040(20)60025-1","article-title":"Supported Co-culture system for investigation of exosomes mediated interactions between breast cancer cells and lung fibroblasts","volume":"48","author":"Zhun","year":"2020","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.critrevonc.2025.105055_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155214","article-title":"Unlocking the potential of exosomes in cancer research: a paradigm shift in diagnosis, treatment, and prevention","volume":"255","author":"Khoushab","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib27","doi-asserted-by":"crossref","first-page":"G397","DOI":"10.1152\/ajpgi.00054.2021","article-title":"The therapeutic potential of exosomes derived from different cell sources in liver diseases","volume":"322","author":"Pan","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib28","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990\u20132015: a systematic analysis for the global burden of disease study","author":"Global","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0867-0","article-title":"Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci","volume":"17","author":"de Araujo Farias","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0306-9877(96)90086-9","article-title":"Cancer as a complex adaptive system","volume":"47","author":"Schwab","year":"1996","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12964-021-00808-w","article-title":"Exosomes: the key of sophisticated cell\u2013cell communication and targeted metastasis in pancreatic cancer","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.105055_bib32","doi-asserted-by":"crossref","first-page":"46710","DOI":"10.18632\/oncotarget.17362","article-title":"Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate","volume":"8","author":"Brennen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12964-024-01584-z","article-title":"The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and-agonist to stimulate growth of target cells","volume":"22","author":"Atri Roozbahani","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.critrevonc.2025.105055_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","article-title":"Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review","volume":"32","author":"Azmi","year":"2013","journal-title":"Cancer Metastas.. Rev."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib35","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eururo.2021.03.005","article-title":"Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer","volume":"80","author":"Kumaraswamy","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","article-title":"Tumor-derived exosomes and their role in cancer progression","volume":"74","author":"Whiteside","year":"2016","journal-title":"Adv. Clin. Chem."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.105055_bib38","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.15252\/embj.201592484","article-title":"ESCRT s are everywhere","volume":"34","author":"Hurley","year":"2015","journal-title":"EMBO J."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105055_bib39","doi-asserted-by":"crossref","first-page":"16820","DOI":"10.1074\/jbc.M112.342667","article-title":"Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons","volume":"287","author":"Koles","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib40","first-page":"8392509","article-title":"Composition, biogenesis, and role of exosomes in tumor development","volume":"2022","author":"Moeinzadeh","year":"2022","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.critrevonc.2025.105055_bib41","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2147\/IJN.S407029","article-title":"Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases","author":"Yuan","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib42","doi-asserted-by":"crossref","first-page":"1588538","DOI":"10.1080\/20013078.2019.1588538","article-title":"Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells","volume":"8","author":"Wu","year":"2019","journal-title":"J. Extracell. vesicles"},{"issue":"7718","key":"10.1016\/j.critrevonc.2025.105055_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","article-title":"Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents","volume":"28","author":"Lin","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.critrevonc.2025.105055_bib45","series-title":"in Urologic Oncology: Seminars and Original Investigations","article-title":"Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer","author":"Kato","year":"2015"},{"key":"10.1016\/j.critrevonc.2025.105055_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2018.00221","article-title":"Exploring small extracellular vesicles for precision medicine in prostate cancer","volume":"8","author":"Giulietti","year":"2018","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib47","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/ijms21062118","article-title":"Exosomes in prostate cancer diagnosis, prognosis and therapy","volume":"21","author":"Lorenc","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib48","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4196","article-title":"Exosomal microRNA remodels the tumor microenvironment","volume":"5","author":"Jiang","year":"2017","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/iju.13145","article-title":"Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression","volume":"23","author":"Liu","year":"2016","journal-title":"Int. J. Urol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105055_bib50","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.2353\/ajpath.2010.090777","article-title":"Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells","volume":"176","author":"Liu","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib51","doi-asserted-by":"crossref","unstructured":"Mashouri, L., et al., Composition, biogenesis, and mechanisms in cancer metastasis and drug resistance., 2019, 18. DOI: https:\/\/doi. org\/10.1186\/s12943-019-0991-5. PMID: https:\/\/www. ncbi. nlm. nih. gov\/pubmed\/30940145: p. 75.","DOI":"10.1186\/s12943-019-0991-5"},{"key":"10.1016\/j.critrevonc.2025.105055_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0772-z","article-title":"Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment","volume":"12","author":"Tian","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib53","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.molpharmaceut.2c00407","article-title":"Immune-cell-derived exosomes for cancer therapy","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib54","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1080\/21645515.2016.1179844","article-title":"Dendritic cell vaccines: a review of recent developments and their potential pediatric application","volume":"12","author":"Elster","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.celrep.2018.06.066","article-title":"ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation","volume":"24","author":"Monypenny","year":"2018","journal-title":"Cell Rep."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.105055_bib56","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.1304718110","article-title":"Human placental trophoblasts confer viral resistance to recipient cells","volume":"110","author":"Delorme-Axford","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib57","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/acs.chemmater.9b00050","article-title":"Surface engineering of extracellular vesicles through chemical and biological strategies","volume":"31","author":"Richardson","year":"2019","journal-title":"Chem. Mater."},{"key":"10.1016\/j.critrevonc.2025.105055_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib59","article-title":"Review on strategies and technologies for exosome isolation and purification","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105055_bib60","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/cancers15102838","article-title":"Surface-engineered extracellular vesicles in cancer immunotherapy","volume":"15","author":"Johnson","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib61","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.critrevonc.2025.105055_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107814","article-title":"The Yin and Yang of exosome isolation methods: conventional practice, microfluidics, and commercial kits","volume":"54","author":"Shirejini","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.critrevonc.2025.105055_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.816656","article-title":"Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in chronic kidney disease","volume":"9","author":"Cao","year":"2022","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib64","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3390\/ijms23073829","article-title":"Mesenchymal stem cell-derived extracellular vesicles and their therapeutic use in central nervous system demyelinating disorders","volume":"23","author":"Allegretta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-07569-7","article-title":"Human infrapatellar fat pad mesenchymal stem cells show immunomodulatory exosomal signatures","volume":"12","author":"Kouroupis","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/pharmaceutics14040733","article-title":"Mesenchymal stem cell-derived extracellular vesicles as non-coding RNA therapeutic vehicles in autoimmune diseases","volume":"14","author":"Martinez-Arroyo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.105055_bib67","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/IJN.S355366","article-title":"Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics","volume":"17","author":"Wang","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib68","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/pharmaceutics14030618","article-title":"Recent advances in the application of mesenchymal stem cell-derived exosomes for cardiovascular and neurodegenerative disease therapies","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.105055_bib69","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jconrel.2023.11.003","article-title":"Immune cell-derived exosomes as promising tools for cancer therapy","volume":"364","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"issue":"42","key":"10.1016\/j.critrevonc.2025.105055_bib70","doi-asserted-by":"crossref","first-page":"44179","DOI":"10.18632\/oncotarget.6175","article-title":"Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.105055_bib71","doi-asserted-by":"crossref","first-page":"1586892","DOI":"10.3389\/fimmu.2025.1586892","article-title":"Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects","volume":"16","author":"Redkin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s13287-025-04519-8","article-title":"The role of stem cell-derived exosomes in regulating pyroptosis for disease therapy","volume":"16","author":"Guo","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13287-024-03783-4","article-title":"CAR-T cell-derived exosomes: a new perspective for cancer therapy","volume":"15","author":"Sani","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbcan.2012.03.006","article-title":"Tumor cell-derived exosomes: a message in a bottle","volume":"1826","author":"Kharaziha","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)Reviews Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib75","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.105055_bib76","author":"Raboshakga","year":"2025","journal-title":"Harnessing therapeutic potential mesenchymal stem cellderived exosomes prostate cancer current insight perspective"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib77","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","article-title":"Dendritic cell\u2013derived exosomes for cancer therapy","volume":"126","author":"Pitt","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib78","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.bbamem.2014.07.026","article-title":"Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro","volume":"1838","author":"Smyth","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA)Biomembr."},{"key":"10.1016\/j.critrevonc.2025.105055_bib79","article-title":"Mesenchymal stem cell-derived exosomes for management of prostate cancer: an updated view","volume":"134","author":"Arab","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biomaterials.2016.09.031","article-title":"Exosome-based tumor antigens\u2013adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA","volume":"111","author":"Morishita","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2025.105055_bib81","series-title":"Prostate cancer exosomes differentiate BM-MSCs into pro-angiogenic and pro-Invasive myofibroblasts","author":"Chowdhury","year":"2015"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib82","doi-asserted-by":"crossref","first-page":"1400370","DOI":"10.1080\/20013078.2017.1400370","article-title":"Biological roles and potential applications of immune cell-derived extracellular vesicles","volume":"6","author":"Wen","year":"2017","journal-title":"J. Extracell. vesicles"},{"key":"10.1016\/j.critrevonc.2025.105055_bib83","series-title":"in Seminars in Cancer Biology","article-title":"Exosomes and prostate cancer management","author":"Vlaeminck-Guillem","year":"2022"},{"key":"10.1016\/j.critrevonc.2025.105055_bib84","doi-asserted-by":"crossref","first-page":"goac075","DOI":"10.1093\/gastro\/goac075","article-title":"Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I","volume":"10","author":"Nazari","year":"2022","journal-title":"Gastroenterol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5483\/BMBRep.2022.55.1.075","article-title":"The therapeutic potential of immune cell-derived exosomes as an alternative to adoptive cell transfer","volume":"55","author":"Hong","year":"2022","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib86","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1021\/acsabm.4c00089","article-title":"Stem cell-derived exosomes: an advanced horizon to cancer regenerative medicine","volume":"7","author":"Ramachandran","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cbin.12098","article-title":"Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney","volume":"48","author":"Saadh","year":"2024","journal-title":"Cell Biol. Int."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105055_bib88","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1002\/cam4.6275","article-title":"Prostate cancer cells synergistically defend against CD8+ T cells by secreting exosomal PD-L1","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s10020-024-00947-z","article-title":"Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1","volume":"30","author":"Shi","year":"2024","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13770-021-00352-1","article-title":"Comparative analysis of MSC-derived exosomes depending on cell culture media for regenerative bioactivity","volume":"18","author":"Kim","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib91","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1021\/acsabm.4c00660","article-title":"Immune cell-derived exosomes: a cell-free cutting-edge tumor immunotherapy","volume":"7","author":"Sengupta","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2025.105055_bib92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in bodily fluids are a highly stable resource of disease biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteom.Clin. Appl."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","article-title":"Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib94","doi-asserted-by":"crossref","first-page":"5802529","DOI":"10.1155\/2016\/5802529","article-title":"Stem cell-derived exosomes: a potential alternative therapeutic agent in orthopaedics","volume":"2016","author":"Burke","year":"2016","journal-title":"Stem Cells Int."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib95","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4252\/wjsc.v12.i8.814","article-title":"Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in regenerative medicine","volume":"12","author":"Ma","year":"2020","journal-title":"World J. stem Cells"},{"key":"10.1016\/j.critrevonc.2025.105055_bib96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcell.2016.00084","article-title":"Biogenesis and function of T cell-derived exosomes","volume":"4","author":"Ventimiglia","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-020-02426-5","article-title":"Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications","volume":"18","author":"Ahmadi","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.105055_bib98","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jconrel.2020.10.037","article-title":"Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy","volume":"329","author":"Takayama","year":"2021","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105055_bib99","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib100","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","article-title":"Digital rectal examination is not a useful screening test for prostate cancer","volume":"6","author":"Krilaviciute","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib101","first-page":"1","article-title":"Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB","volume":"19","author":"Li","year":"2021","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105055_bib102","first-page":"3224","article-title":"The role and mechanism of miR-374 regulating the malignant transformation of mesenchymal stem cells","volume":"10","author":"Sun","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib103","doi-asserted-by":"crossref","first-page":"20924","DOI":"10.1038\/s41598-022-23204-x","article-title":"The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines","volume":"12","author":"Rezaeian","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.105055_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1488-1","article-title":"Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.31083\/j.fbl2709256","article-title":"Targeting castration-resistant prostate cancer using mesenchymal stem cell exosomes for therapeutic MicroRNA-let-7c delivery","volume":"27","author":"Kurniawati","year":"2022","journal-title":"Front. Biosci. Landmark"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2123675","article-title":"Suppressive function of bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-187 in prostate cancer","volume":"23","author":"Li","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib107","first-page":"1779346","article-title":"Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy","volume":"2022","author":"Chen","year":"2022","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib108","doi-asserted-by":"crossref","first-page":"2285836","DOI":"10.1080\/15476278.2023.2285836","article-title":"Regulation of interferon-\u03b2-modified human umbilical cord mesenchymal stem cell-derived exosomes in proliferation and apoptosis of prostate cancer cells","volume":"19","author":"Yuan","year":"2023","journal-title":"Organogenesis"},{"key":"10.1016\/j.critrevonc.2025.105055_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2023.102078","article-title":"Regulatory mechanism of DHRS2-modified human umbilical cord mesenchymal stem cells-derived exosomes in prostate cancer cell proliferation and apoptosis","volume":"82","author":"Wu","year":"2023","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/stem.1619","article-title":"Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes","volume":"32","author":"Abd Elmageed","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.critrevonc.2025.105055_bib111","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2025.105055_bib112","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","article-title":"Recent progresses in exosome-based systems for targeted drug delivery to the brain","volume":"348","author":"Bashyal","year":"2022","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib113","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105055_bib114","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.4049\/jimmunol.176.5.2722","article-title":"Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines","volume":"176","author":"Taieb","year":"2006","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105055_bib115","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1158\/0008-5472.CAN-11-2154","article-title":"Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells","volume":"71","author":"Nierkens","year":"2011","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib116","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00262-025-04070-8","article-title":"Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer","volume":"74","author":"Fan","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib117","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41585-021-00488-8","article-title":"The potential of CAR T cell therapy for prostate cancer","volume":"18","author":"Wolf","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105055_bib118","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1002\/jcp.29784","article-title":"Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer","volume":"235","author":"Guan","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib119","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-022-03494-5","article-title":"Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9\/circMID1\/miR-506-3p\/MID1","volume":"20","author":"Gao","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.105055_bib120","first-page":"1","article-title":"Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression","author":"Guan","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2025.105055_bib121","doi-asserted-by":"crossref","first-page":"1580314","DOI":"10.3389\/fonc.2025.1580314","article-title":"The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer","volume":"15","author":"Song","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib122","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/10717544.2022.2044937","article-title":"Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib123","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12967-025-06814-7","article-title":"Tumor-derived exosomes and their application in cancer treatment","volume":"23","author":"Javdani-Mallak","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.105055_bib124","article-title":"Insights into tumor-derived exosome inhibition in cancer therapy","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108925","article-title":"Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion","volume":"9","author":"Lundholm","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib126","doi-asserted-by":"crossref","first-page":"1368823","DOI":"10.1080\/20013078.2017.1368823","article-title":"Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes","volume":"6","author":"Salimu","year":"2017","journal-title":"J. Extracell. vesicles"},{"key":"10.1016\/j.critrevonc.2025.105055_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01686-x","article-title":"Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1","volume":"21","author":"Dai","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12865-022-00514-3","article-title":"Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer","volume":"23","author":"Peng","year":"2022","journal-title":"BMC Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/aja202351","article-title":"Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS\/miR-214-3p\/CCL5 pathway","volume":"26","author":"Yang","year":"2024","journal-title":"Asian J. Androl."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s12951-024-03025-y","article-title":"Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors","volume":"22","author":"Chen","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2025.105055_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109109","article-title":"Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105055_bib132","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/cancers11091276","article-title":"Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells","volume":"11","author":"Mezzasoma","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib133","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pros.23996","article-title":"Antitumor efficacy of interferon-\u03b3-modified exosomal vaccine in prostate cancer","volume":"80","author":"Shi","year":"2020","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib134","first-page":"8580043","article-title":"The roles of tumor-associated macrophages in prostate cancer","volume":"2022","author":"Han","year":"2022","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2022.05.037","article-title":"Tumor-derived extracellular vesicles predict clinical outcomes in oligometastatic prostate cancer and suppress antitumor immunity","volume":"114","author":"Lucien","year":"2022","journal-title":"Int. J. Radiat. Oncol. * Biol. * Phys."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073528","article-title":"Role of exosomes in prostate cancer metastasis","volume":"22","author":"Akoto","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib137","doi-asserted-by":"crossref","first-page":"288","DOI":"10.20517\/2394-4722.2017.32","article-title":"Prostate cancer exosomes as modulators of the tumor microenvironment","volume":"3","author":"Shephard","year":"2017","journal-title":"J. Cancer Metastas.. Treat."},{"key":"10.1016\/j.critrevonc.2025.105055_bib138","doi-asserted-by":"crossref","first-page":"1100892","DOI":"10.3389\/fbioe.2022.1100892","article-title":"Recent developments in isolating methods for exosomes","volume":"10","author":"Gao","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12033-021-00300-3","article-title":"Elucidating methods for isolation and quantification of exosomes: a review","volume":"63","author":"Kurian","year":"2021","journal-title":"Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib140","doi-asserted-by":"crossref","first-page":"1596016","DOI":"10.1080\/20013078.2019.1596016","article-title":"Extracellular vesicle measurements with nanoparticle tracking analysis\u2013an accuracy and repeatability comparison between NanoSight NS300 and ZetaView","volume":"8","author":"Bachurski","year":"2019","journal-title":"J. Extracell. vesicles"},{"key":"10.1016\/j.critrevonc.2025.105055_bib141","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5772\/61148","article-title":"Size exclusion HPLC detection of small-size impurities as a complementary means for quality analysis of extracellular vesicles","volume":"4","author":"Huang","year":"2015","journal-title":"J. Circ. Biomark."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105055_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145686","article-title":"Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods","volume":"10","author":"Baranyai","year":"2015","journal-title":"PloS One"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.105055_bib143","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2217\/nnm-2016-0102","article-title":"Post isolation modification of exosomes for nanomedicine applications","volume":"11","author":"Hood","year":"2016","journal-title":"Nanomedicine"},{"issue":"134","key":"10.1016\/j.critrevonc.2025.105055_bib144","article-title":"Protein digestion, ultrafiltration, and size exclusion chromatography to optimize the isolation of exosomes from human blood plasma and serum","author":"Diaz","year":"2018","journal-title":"J. Vis. Exp. JoVE"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/cvr\/cvx118","article-title":"Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis","volume":"113","author":"Ribeiro-Rodrigues","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"45","key":"10.1016\/j.critrevonc.2025.105055_bib146","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1039\/D3AY01704D","article-title":"A comparison of size exclusion chromatography-based tandem strategies for plasma exosome enrichment and proteomic analysis","volume":"15","author":"Bai","year":"2023","journal-title":"Anal. Methods"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib147","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1515\/chem-2022-0139","article-title":"Comparison of the yield and purity of plasma exosomes extracted by ultracentrifugation, precipitation, and membrane-based approaches","volume":"20","author":"Li","year":"2022","journal-title":"Open Chem."},{"key":"10.1016\/j.critrevonc.2025.105055_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.125790","article-title":"Bifunctional immunoaffinity magnetic nanoparticles for high-efficiency separation of exosomes based on host-guest interaction","volume":"272","author":"Pei","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.critrevonc.2025.105055_bib149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bmt.2022.11.001","article-title":"Microfluidics-derived microcarrier systems for oral delivery","volume":"1","author":"Cai","year":"2023","journal-title":"Biomed. Technol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/pharmaceutics17080990","article-title":"Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and future directions","volume":"17","author":"Verma","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.105055_bib151","article-title":"Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics","volume":"2","author":"Cheng","year":"2023","journal-title":"Extracell. Vesicle"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib152","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib153","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fonc.2019.00858","article-title":"Androgen receptor signaling in the development of castration-resistant prostate cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib154","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/biology11060813","article-title":"The dual role of mesenchymal stromal cells and their extracellular vesicles in carcinogenesis","volume":"11","author":"Gilazieva","year":"2022","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib155","doi-asserted-by":"crossref","first-page":"2101050","DOI":"10.1002\/adbi.202101050","article-title":"Mesenchymal stem cell exosomes and cancer: controversies and prospects","volume":"6","author":"Yassine","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib156","first-page":"147","article-title":"Mesenchymal stem cells as regulators of carcinogenesis","author":"Hayal","year":"2019","journal-title":"Cell Biology Translational Medicine Volume 5 Stem Cells Translational Science Therapy"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib157","doi-asserted-by":"crossref","first-page":"390","DOI":"10.21037\/tau.2018.03.07","article-title":"Chemotherapy and radiation for prostate cancer","volume":"7","author":"Hurwitz","year":"2018","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib158","doi-asserted-by":"crossref","first-page":"1115786","DOI":"10.3389\/fcell.2022.1115786","article-title":"Mesenchymal stromal\/stem cell-derived exosomes and genitourinary cancers: a mini review","volume":"10","author":"Salehpour","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib159","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biomaterials.2016.03.023","article-title":"A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer","volume":"91","author":"Levy","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcyt.2018.11.011","article-title":"The use of unlicensed bone marrow\u2013derived platelet lysate\u2013expanded mesenchymal stromal cells in colitis: a pre-clinical study","volume":"21","author":"Salmenkari","year":"2019","journal-title":"Cytotherapy"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105055_bib161","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.critrevonc.2025.105055_bib162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-019-03526-7","article-title":"Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration","volume":"458","author":"Xie","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib163","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.18632\/oncotarget.6540","article-title":"Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche","volume":"7","author":"S\u00e1nchez","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib164","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7150\/ntno.28450","article-title":"Intelligent photosensitive mesenchymal stem cells and cell-derived microvesicles for photothermal therapy of prostate cancer","volume":"3","author":"Huang","year":"2019","journal-title":"Nanotheranostics"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/polyeng-2023-0166","article-title":"Biopolymer-based nanocomposites for application in biomedicine: a review","volume":"44","author":"Shaikh","year":"2024","journal-title":"J. Polym. Eng."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib166","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13287-025-04133-8","article-title":"Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review","volume":"16","author":"Wang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105055_bib167","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.3390\/cells10123278","article-title":"Mesenchymal stem\/stromal cells derived from human and animal perinatal tissues\u2014origins, characteristics, signaling pathways, and clinical trials","volume":"10","author":"Kulus","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib168","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","article-title":"Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years?","volume":"18","author":"Galderisi","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib169","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/wound.2024.0093","article-title":"Standardized reporting of research on exosomes to ensure rigor and reproducibility","volume":"13","author":"Yadav","year":"2024","journal-title":"Adv. Wound Care"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib170","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.top074476","article-title":"Strategies for isolation of exosomes","volume":"2015","author":"Zeringer","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.critrevonc.2025.105055_bib171","series-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles","first-page":"26913","author":"L\u00f6tvall","year":"2014"},{"key":"10.1016\/j.critrevonc.2025.105055_bib172","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic cells and CD8 T cell immunity in tumor microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib173","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.1038\/srep20254","article-title":"Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets","volume":"6","author":"Muller","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.105055_bib174","first-page":"1","article-title":"CAR T-cell therapy and critical care: a survival guide for medical emergency teams","author":"Messmer","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/14686996.2022.2133342","article-title":"Advances of engineered extracellular vesicles-based therapeutics strategy","volume":"23","author":"Komuro","year":"2022","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s12276-023-01132-8","article-title":"Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications","volume":"56","author":"Jung","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.105055_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.trecan.2024.07.010","article-title":"Advances in exosomes utilization for clinical applications in cancer","author":"Batista","year":"2024","journal-title":"Trends Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105055_bib178","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3390\/cancers13153667","article-title":"DC-derived exosomes for cancer immunotherapy","volume":"13","author":"Yao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.105055_bib179","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/s1677-5538.ibju.2019.0409","article-title":"Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer","volume":"46","author":"Nayak","year":"2020","journal-title":"Int. Braz. J. Urol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib180","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.7150\/ijbs.41105","article-title":"B7-H3, a checkpoint molecule, as a target for cancer immunotherapy","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105055_bib181","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00432-022-04213-9","article-title":"The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer","volume":"148","author":"de N\u00f3brega","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib182","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib183","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41598-019-56542-4","article-title":"Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib184","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41571-019-0173-9","article-title":"Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC","volume":"16","author":"Camidge","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105055_bib185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12032-023-02176-6","article-title":"Theranostic signature of tumor-derived exosomes in cancer","volume":"40","author":"Kumar","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2016.01.028","article-title":"PLK-1 silencing in bladder cancer by siRNA delivered with exosomes","volume":"91","author":"Greco","year":"2016","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib187","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s13139-016-0439-4","article-title":"Influence of androgen deprivation therapy on the uptake of PSMA-targeted agents: emerging opportunities and challenges","volume":"51","author":"Bakht","year":"2017","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib188","doi-asserted-by":"crossref","first-page":"442","DOI":"10.21037\/tau-23-533","article-title":"Extracellular vesicles and prostate cancer management: a narrative review","volume":"13","author":"Urabe","year":"2024","journal-title":"Transl. Androl. Urol."},{"issue":"28","key":"10.1016\/j.critrevonc.2025.105055_bib189","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2217\/fon-2017-0343","article-title":"The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy","volume":"13","author":"Whiteside","year":"2017","journal-title":"Future Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105055_bib190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ijc.35241","article-title":"Engineered exosomes in service of tumor immunotherapy: From optimizing tumor-derived exosomes to delivering CRISPR\/Cas9 system","volume":"156","author":"Jiang","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib191","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21147\/j.issn.1000-9604.2024.02.05","article-title":"New roles of tumor-derived exosomes in tumor microenvironment","volume":"36","author":"Chen","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.105055_bib192","article-title":"Peptide-based electrochemical detection of prostate cancer-derived exosomes using a dual signal amplification strategy","volume":"7","author":"Li","year":"2024","journal-title":"Sens. Actuators Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib193","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/biof.2036","article-title":"Harnessing tumor-derived exosomes: a promising approach for the expansion of clinical diagnosis, prognosis, and therapeutic outcome of prostate cancer","volume":"50","author":"Pirouzpanah","year":"2024","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105055_bib194","article-title":"Exosome-derived microRNA: efficacy in cancer","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41391-022-00521-w","article-title":"Diagnostic and prognostic significance of extracellular vesicles in prostate cancer drug resistance: a systematic review of the literature","volume":"26","author":"Grimaldi","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.critrevonc.2025.105055_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113093","article-title":"Exosomes from prostate cancer cell lines: isolation optimisation and characterisation","volume":"151","author":"Bertokova","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib197","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/cancers11030429","article-title":"A pilot clinical study on the prognostic relevance of plasmatic exosomes levels in oral squamous cell carcinoma patients","volume":"11","author":"Rodr\u00edguez Zorrilla","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib198","doi-asserted-by":"crossref","DOI":"10.2196\/24423","article-title":"Presence of urinary exosomes for liquid biopsy of clear cell renal cell carcinoma: protocol for a pilot feasibility study","volume":"10","author":"Li","year":"2021","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.critrevonc.2025.105055_bib199","article-title":"Exosome as drug delivery system: Current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.critrevonc.2025.105055_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101542","article-title":"An overview of prostate cancer (PCa) diagnosis: potential role of miRNAs","volume":"26","author":"Bilal","year":"2022","journal-title":"Transl. Oncol."},{"issue":"25","key":"10.1016\/j.critrevonc.2025.105055_bib201","doi-asserted-by":"crossref","first-page":"21740","DOI":"10.18632\/oncotarget.3226","article-title":"Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel","volume":"6","author":"Kharaziha","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.105055_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155471","article-title":"Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients","volume":"141","author":"Mac\u00edas","year":"2021","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib203","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/cancers13040780","article-title":"Prognostic significance of gene expression and DNA methylation markers in circulating tumor cells and paired plasma derived exosomes in metastatic castration resistant prostate cancer","volume":"13","author":"Zavridou","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib204","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ncomms2282","article-title":"Delivery of chemotherapeutic drugs in tumour cell-derived microparticles","volume":"3","author":"Tang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.105055_bib205","first-page":"908","article-title":"BRCA germline mutations in prostate cancer: the future is tailored","author":"Crocetto","year":"2021","journal-title":"MDPI"},{"key":"10.1016\/j.critrevonc.2025.105055_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2023.100126","article-title":"Harnessing liquid biopsies: exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine","volume":"2","author":"Bamodu","year":"2023","journal-title":"J. Liq. Biopsy"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.105055_bib207","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/ijms21186466","article-title":"A review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib208","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070047","article-title":"Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer","volume":"8","author":"Gabriel","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib209","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers5041522","article-title":"Exosomes in prostate cancer: putting together the pieces of a puzzle","volume":"5","author":"Soekmadji","year":"2013","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105055_bib210","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.18632\/oncotarget.7052","article-title":"Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment","volume":"7","author":"Hosseini-Beheshti","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105055_bib211","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3892\/ijo.2014.2256","article-title":"Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103198","article-title":"First-line systemic therapy for metastatic castration-sensitive prostate cancer: an updated systematic review with novel findings","volume":"157","author":"Ferro","year":"2021","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib213","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.3390\/ijms22073528","article-title":"Role of exosomes in prostate cancer metastasis","volume":"22","author":"Akoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib214","doi-asserted-by":"crossref","first-page":"S530","DOI":"10.1016\/j.annonc.2020.08.909","article-title":"650P Comparing the predictive value of exosome, circulating tumor cells, and tumor tissue in detecting AR-V7 among metastatic castration-resistant prostate cancer treated with abiraterone","volume":"31","author":"Zhu","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105055_bib215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.matbio.2018.08.004","article-title":"Prostate cancer sheds the \u03b1v\u03b23 integrin in vivo through exosomes","volume":"77","author":"Krishn","year":"2019","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib216","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3892\/ijo.2016.3560","article-title":"Exosome-derived microRNAs contribute to prostate cancer chemoresistance","volume":"49","author":"Li","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105055_bib217","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New technologies for analysis of extracellular vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib218","doi-asserted-by":"crossref","first-page":"31292","DOI":"10.3402\/jev.v5.31292","article-title":"Exosomal miRNAs as cancer biomarkers and therapeutic targets","volume":"5","author":"Thind","year":"2016","journal-title":"J. Extracell. vesicles"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib219","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40364-023-00538-w","article-title":"Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers","volume":"11","author":"Zhou","year":"2023","journal-title":"Biomark. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105055_bib220","first-page":"3419","article-title":"Isolation of prostate cancer-related exosomes","volume":"34","author":"Mizutani","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2025.105055_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.625722","article-title":"Circular RNAs are promising biomarkers in liquid biopsy for the diagnosis of non-small cell lung cancer","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2025.105055_bib222","doi-asserted-by":"crossref","unstructured":"Foj, L., et al., Exosomal and non-exosomal urinary miRNAs in prostate cancer detection and prognosis. The Prostate, 2017. 77(6): p. 573-583.","DOI":"10.1002\/pros.23295"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib223","doi-asserted-by":"crossref","first-page":"2300258","DOI":"10.1002\/adbi.202300258","article-title":"Exosomes as theranostic agents in reproduction system","volume":"8","author":"Izadpanah","year":"2024","journal-title":"Adv. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib224","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12964-022-01017-9","article-title":"The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases","volume":"21","author":"Oveili","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.critrevonc.2025.105055_bib225","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00580-014-2053-0","article-title":"Isolation, culture, characterization, and adipogenic differentiation of heifer endometrial mesenchymal stem cells","volume":"24","author":"Mehrabani","year":"2015","journal-title":"Comp. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105055_bib226","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14712598.2020.1813276","article-title":"The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer","volume":"21","author":"Czystowska-Kuzmicz","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib227","doi-asserted-by":"crossref","first-page":"6272498","DOI":"10.1155\/2020\/6272498","article-title":"Tumor-derived exosomes in immunosuppression and immunotherapy","volume":"2020","author":"Olejarz","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105055_bib228","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7150\/jca.81933","article-title":"Endoplasmic reticulum stress promotes prostate cancer cells to release exosome and up-regulate PD-L1 expression via PI3K\/Akt signaling pathway in macrophages","volume":"14","author":"Xu","year":"2023","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105055_bib229","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12672-024-01259-8","article-title":"The roles of exosomes in esophageal cancer","volume":"15","author":"Sun","year":"2024","journal-title":"Discov. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:42:30Z","timestamp":1768333350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825004433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":229,"alternative-id":["S1040842825004433"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105055","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the therapeutic potential of exosomes derived from different cells for the treatment of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105055"}}